These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34447372)

  • 21. European multicenter study on the real-world use and clinical impact of extracorporeal photopheresis after heart transplantation.
    Barten MJ; Sax B; Schopka S; Amarelli C; Epailly E; Natali B; Teszák T; Gökler J; Borchert K; Theil J; Ingram A; Zuckermann A
    J Heart Lung Transplant; 2023 Aug; 42(8):1131-1139. PubMed ID: 37037751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updating ECP action mechanisms.
    Heshmati F
    Transfus Apher Sci; 2014 Jun; 50(3):330-9. PubMed ID: 24837416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.
    Baskaran G; Tiriveedhi V; Ramachandran S; Aloush A; Grossman B; Hachem R; Mohanakumar T
    J Heart Lung Transplant; 2014 Sep; 33(9):950-6. PubMed ID: 24906794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracorporeal photopheresis in heart transplant rejection.
    Patel J; Klapper E; Shafi H; Kobashigawa JA
    Transfus Apher Sci; 2015 Apr; 52(2):167-70. PubMed ID: 25748232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection.
    Lorenz K; Rommel K; Mani J; Jin N; Hilgendorf I; Ho AD; Freund M; Schmitt M; Schmitt A
    Leuk Lymphoma; 2015 Mar; 56(3):671-5. PubMed ID: 24913503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease.
    Gorgun G; Miller KB; Foss FM
    Blood; 2002 Aug; 100(3):941-7. PubMed ID: 12130506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extracorporeal photochemotherapy].
    Viguier M; Pouthier F; Tiberghien P; Aubin F
    Transfus Clin Biol; 2010 Feb; 17(1):28-33. PubMed ID: 20042357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal photopheresis: technique, established and novel indications.
    Marques MB; Adamski J
    J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients.
    Di Renzo M; Sbano P; De Aloe G; Pasqui AL; Rubegni P; Ghezzi A; Auteri A; Fimiani M
    Clin Exp Immunol; 2008 Mar; 151(3):407-13. PubMed ID: 18234053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T Cells in Chronic Graft-Versus-Host Disease After Extracorporeal Photopheresis: Correlation With Skin and Global Organ Responses, and Ability to Taper Steroids.
    Denney HA; Whittle RJ; Lai J; Jacques RM; Taylor PC
    Transplantation; 2017 Jan; 101(1):204-211. PubMed ID: 27007227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.
    Akhtari M; Giver CR; Ali Z; Flowers CR; Gleason CL; Hillyer CD; Kaufman J; Khoury HJ; Langston AA; Lechowicz MJ; Lonial S; Renfroe HM; Roback JD; Tighiouart M; Vaughn L; Waller EK
    Transfusion; 2010 Nov; 50(11):2424-31. PubMed ID: 20529004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology.
    Tsirigotis P; Kapsimalli V; Baltadakis I; Kaloyannidis P; Karakasis D; Papalexandri A; Psarra E; Nosi E; Konsta E; Vikentiou M; Papageorgiou S; Sakellari I; Pappa V; Harhalakis N; Anagnostopoulos A; Dervenoulas J
    Transfus Apher Sci; 2012 Apr; 46(2):181-8. PubMed ID: 22115608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance.
    Kusztal M; Kłak R; Krajewska M; Boratyńska M; Patrzałek D; Klinger M
    Transplant Proc; 2011 Oct; 43(8):2941-2. PubMed ID: 21996195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic insights into extracorporeal photochemotherapy: efficient induction of monocyte-to-dendritic cell maturation.
    Edelson RL
    Transfus Apher Sci; 2014 Jun; 50(3):322-9. PubMed ID: 23978554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on extracorporeal photopheresis in heart and lung transplantation.
    Marques MB; Schwartz J
    J Clin Apher; 2011; 26(3):146-51. PubMed ID: 21647952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection.
    Dall'Amico R; Livi U; Milano A; Montini G; Andreetta B; Murer L; Zacchello G; Thiene G; Casarotto D; Zacchello F
    Transplantation; 1995 Jul; 60(1):45-9. PubMed ID: 7624941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis.
    Coppard C; Hannani D; Humbert M; Gauthier V; Plumas J; Merlin E; Gabert F; Chaperot L
    J Clin Apher; 2019 Aug; 34(4):450-460. PubMed ID: 30860623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series.
    Xipell M; Molina-Andújar A; Cid J; Piñeiro GJ; Montagud-Marrahi E; Cofan F; Oppenheimer F; Rovira J; Diekmann F; Lozano M
    J Clin Apher; 2022 Jun; 37(3):197-205. PubMed ID: 34936110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.